Opendata, web and dolomites
H2020 projects about "relapse"
The page lists 75 projects related to the topic "relapse".
| # | |||
|---|---|---|---|
| 1 | COLOStage | COLOStage : A new prognosis test for the prediction of metastasis in Colorectal Cancer and Hepatocellular Carcinoma | 2015 |
| 2 | NoHoW | Evidence-based ICT tools for weight loss maintenance | 2015 |
| 3 | GENMETASTEM | GENOMIC AND METABOLIC REGULATION OF METASTATIC CANCER STEM CELLS | 2016 |
| 4 | ReconsolidationDynamics | A Cross-Species Investigation of Memory Replay During Reconsolidation | 2015 |
| 5 | FiBRO | Fibroblasts in the Biology of Rectal Cancer Progression | 2016 |
| 6 | URO-BEST | UROthelial carcinoma Biomarker based diagnostic tEST | 2015 |
| 7 | EpiTALL | Dynamic interplay between DNA methylation, histone modifications and super enhancer activity in normal T cells and during malignant T cell transformation | 2015 |
| 8 | CSC-IS | Development of a more effective and safer therapeutic antibody for cancer treatment with a dual mechanism of action to eliminate CSCs and reactivate the tumour’s immune system. | 2015 |
| 9 | ISPIC | Image-Guided Surgery (IGS) and Personalised Postoperative Immunotherapy To Improving Cancer Outcome | 2016 |
| 10 | Cancer-Recurrence | Tumor cell death supports recurrence of cancer | 2015 |
| 11 | ENERGY SPECTRUM | Market uptake a innovative Non-intrusive Appliance Load Monitoring (NIALM) to enlarge ENERGY efficiency SPECTRUM to comprise the families factor | 2016 |
| 12 | SyBil-AA | Systems Biology of Alcohol Addiction: Modeling and validating disease state networks in human and animal brains for understanding pathophysiolgy, predicting outcomes and improving therapy | 2016 |
| 13 | AML-VACCiN | Clinical development of a dendritic-cell vaccine therapy for acute myeloid leukaemia | 2016 |
| 14 | MAINTRAC-Auto | MAINTRAC-Auto: Automatization and validation of a liquid biopsy assay “Maintrac-AUTO CTC-analyser” for predictive real time monitoring and success control of solid tumor cancer therapy | 2016 |
| 15 | SLIM | Synthetic Lethal Interactions with nucleophosMin 1 | 2016 |
| 16 | HEAL-BY-MIRNA | microRNA replacement therapy for mature B cell neoplasias | 2016 |
| 17 | CLONCELLBREAST | CLONAL AND CELLULAR HETEROGENEITY OF BREAST CANCER AND ITS DYNAMIC EVOLUTION WITH TREATMENT | 2017 |
| 18 | LeukaemiaTargeted | Selecting genetic lesions with essential function for patients' leukaemia in vivo as targets for precision medicine | 2016 |
| 19 | NO-META | Feasibility study of a NOvel METAbolic liquid biopsy for cancer therapy monitoring | 2016 |
| 20 | MYELOMANEXT | Integrated next-generation flow cytometry and sequencing to uncover the pathway of curability in multiple myeloma | 2016 |
| 21 | STRESNET | Stress Resilience and Network-Feedback Training | 2016 |
| 22 | ADC | Next-Generation Antibody-Drug Conjugates for safer and more effective cancer therapies | 2016 |
| 23 | ADST | Advanced Digital Stuttering Therapy Tools | 2016 |
| 24 | DiVineGenoMe | Decoding cell-to-cell variation in genome integrity maintenance | 2017 |
| 25 | McHAP | Entrapment of Hypoxic Cancer by Macrophages Loaded with HAP | 2017 |
| 26 | VIVAVE | Viral Vaccine Vectors in Personalized Medicine | 2017 |
| 27 | MAMLE | Understanding the mechanisms of human acute myeloid leukaemia (AML) evolution | 2017 |
| 28 | BGCI | Bacterial Ghost Cancer Immunotherapy - A new standard in tumour therapy based on the bacterial ghost platform technology | 2017 |
| 29 | PREDICT | PREcision medicine Drug combination testing In neuroblastoma organoids to guide Clinical Trials | 2017 |
| 30 | RADAR-CNS | Remote Assessment of Disease and Relapse in Central Nervous System Disorders - Sofia ref.: 115902 | 2016 |
| 31 | CINK | Advancing cancer immunotherapy using natural killer cells for hematological and metastatic cancers | 2018 |
| 32 | METCLL | Discovery and validation of ‘epidrivers’ of cancer evolution and resistance to therapy | 2018 |
| 33 | PHRD | The development of Personalised Host Response Diagnostic kit | 2017 |
| 34 | BEAT | The functional interaction of EGFR and beta-catenin signalling in colorectal cancer: Genetics, mechanisms, and therapeutic potential. | 2017 |
| 35 | BLMs 4 TB | Beta-lactams for Tuberculosis Treatment | 2018 |
| 36 | MESI-STRAT | Systems Medicine of Metabolic-Signaling Networks: A New Concept for Breast Cancer Patient Stratification | 2018 |
| 37 | R-LiNK | Optimizing response to Li treatment through personalized evaluation of individuals with bipolar I disorder: the R-LiNK initiative | 2018 |
| 38 | INSITUMUT | Direct detection of cancer-causing mutations in tumour specimens | 2018 |
| 39 | AltCheM | In vivo functional screens to decipher mechanisms of stochastically- and mutationally-induced chemoresistance in Acute Myeloid Leukemia | 2018 |
| 40 | CombaTCancer | Rational combination therapies for metastatic cancer | 2018 |
| 41 | CANCER | Personalised Postoperative Immunotherapy To Improving Cancer Outcome and improving quality of life | 2018 |
| 42 | ITHACA | Immuno-targeting of human AML quiescent cells by a novel phage display approach. | 2018 |
| 43 | FeedHypNet | Dynamic regulation of feeding behaviors in health and disease by top-down control of hypothalamic networks | 2018 |
| 44 | HifLICs | Acute Myeloid Leukemia Leukemic Initiating Cells: Contribution of hypoxia/HIF pathway to chemoresistance and relapse | 2019 |
| 45 | InTheMLLrBALL | Innovative Therapeutic Strategies for Mixed Lineage Leukemia-rearranged B-cell Acute Lymphoblastic Leukemia | 2018 |
| 46 | Multiple Sclerosis | Development of a Functionalised Biomaterial Scaffold to Treat Multiple Sclerosis | 2018 |
| 47 | EDIT | Novel precision technological platforms to promote non-invasive early diagnosis, eradication and prevention of cancer relapse: proof of concept in the bladder carcinoma. | 2018 |
| 48 | LapIt | Making AML treatment a clinical reality: A novel anti-IL7 receptor antibody to deliver Lap to 5LO positive cells | 2019 |
| 49 | IT4B-ALL | Therapeutic immunotherapy targeting NG2 and CD22 antigens for MLL-rearranged and MLL-germline B-cell Acute Lymphoblastic Leukemia | 2019 |
| 50 | STARNEL | supracellular contractility of myofibroblasts in gut homeostasis and cancer invasion | 2018 |
| 51 | NEFERTITI | NEFERTITI: A Novel Eco-Friendly, dually Efficient and Resistance-free Treatment of vaginITIs | 2018 |
| 52 | CONQR | Translation and Commercialization of a QSOX1-inhibitory Antibody Targeting the Tumor Microenvironment in Breast Cancer | 2018 |
| 53 | SELNET | Sarcoma as a model to improve diagnosis and clinical care of rare tumors through a European and Latin American multidisciplinary network | 2019 |
| 54 | METANICHE | Regulation of bone metastases by age-associated angiocrine signals | 2019 |
| 55 | scTALLmap | Single-cell map of the composition and evolution of T-cell acute lymphoblastic leukemia | 2019 |
| 56 | TRACERxTME | Constructing an evolutionary atlas of the immune landscape in lung cancer | 2019 |
| 57 | EVOMET | The rise and fall of metastatic clones under immune attack | 2019 |
| 58 | EndoPos | Endosome positioning in tumour-stroma interactions | 2019 |
| 59 | PRINT-CHEMO | To develop 3D bioPRINTed osteoinductive constructs that deliver CHEMOtherapeutics within large bone defects that are surgically created when removing bone tumours. | 2019 |
| 60 | PhotoStem | Photoswitching molecules for the spatiotemporal control of cancer stem cells with light | 2019 |
| 61 | SLIPPED | Maintenance and relapse in long-term desistance from crime and recovery from addiction | 2019 |
| 62 | FUNTRICAN | Functional analysis of thyroid hormone nuclear receptors TRs in human Intestinal Cancer stem cells | 2019 |
| 63 | QuiescStemGBM | Studying the role of Quiescent Cancer Stem Cells in GBM development using a novel in vivo cell cycle-based approach | 2020 |
| 64 | ONCO-BOOST | Boosting immuno-oncology strategies with innovative immuno-stimulants derived from bacteria, to be administrated in combination with therapeutic monoclonal antibodies | 2019 |
| 65 | TRIC-TB | Boosting Ethionamide efficacy and lowering the dose with a small molecule transcriptional modulators, to overcoming MDR-TB infections and define a new place for Ethionamide in 1st-line TB treatments. | 2019 |
| 66 | TK-NEO | Personalized Cancer Immunotherapy through DNA-EP vaccines | 2019 |
| 67 | PrevictDrugs | Smartphone Measured Eye-Based Digital Biomarkers for Drug Use Detection | 2019 |
| 68 | PexyEazy | PexyEazy® - an innovative surgical device for treatment of haemorrhoids. | 2019 |
| 69 | RV001 | RV001: An anti-metastatic cancer vaccine | 2019 |
| 70 | CADISS | A medical device for the selective dissection of pathological tissues and fibrosis | 2019 |
| 71 | ASCAPE | Artificial intelligence Supporting CAncer Patients across Europe | 2020 |
| 72 | ALTER-brain | Metastasis-associated altered molecular patterns in the brain | 2020 |
| 73 | PregnancyAD | Antidepressant discontinuation during pregnancy and relapse risk in the perinatal period | 2021 |
| 74 | PRECISMEDLYM | Aggressive T cell Lymphomas, integrated clinical and genomic analysis for a precision medicine. | 2020 |
| 75 | SkinMicrobiome | Paradigm Change in Skin Health: Novel Microbiome-based Cosmetics for Acne and Other Skin Conditions | 2020 |